TREM2 and Alzheimer disease: TREM2 inhibition may be useful in conditions where microglial phagocytosis aggravates neuronal damage and neuroinflammation, such as in the later stages of AD, when excessive microglial activation contributes to synaptic loss and cognitive decline [152].